project id: TCGA-SKCM; case submitter id: TCGA-FS-A1ZW; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.85; concentration: 0.16; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.6; rna integrity number: 7.9; age at index: 65; days to birth: -24087; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1940; age at diagnosis: 24087; ajcc pathologic m: M0; ajcc pathologic n: N1a; ajcc pathologic stage: Stage IIIB; ajcc pathologic t: T2b; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1505.0; icd 10 code: C77.9; last known disease status: not reported; morphology: 8720/3; primary diagnosis: Malignant melanoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lymph node, NOS; synchronous malignancy: No; tissue or organ of origin: Skin, NOS; tumor grade: Not Reported; year of diagnosis: 2005; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 2084; days to sample procurement: 0; portion submitter id: TCGA-FS-A1ZW-06A-12; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 95.0;